Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-04-2020 | Allergic Rhinitis | Rhinology

The role of regulatory T cells in allergic rhinitis and their correlation with IL-10, IL-17 and neopterin levels in serum and nasal lavage fluid

Authors: Kadriye Erkan, Mete K. Bozkurt, Hasibe Artaç, Hülya Özdemir, Ali Ünlü, Emine N. Korucu, Çağdaş Elsürer

Published in: European Archives of Oto-Rhino-Laryngology | Issue 4/2020

Abstract

Purpose

Allergic rhinitis (AR), is an IgE-mediated inflammation of the nose. Regulatory T cells (Tregs) and inflammatory cytokines have been shown to play a critical role in allergic airway inflammation. The aim of the study was to compare the levels of blood T lymphocyte subsets and IL-10, IL-17 and neopterin concentrations in serum and nasal lavage of patients with AR compared to healthy subjects.

Methods

The study included 38 subjects with moderate-severe AR and 36 sex- and age-matched controls. Peripheral blood CD3+, CD3+CD4+ and CD4+CD25+Foxp3 percentages were evaluated using flow cytometry. Levels of IL-10, IL-17 and neopterin were measured both in serum and nasal lavage fluid with ELISA and HPLC, respectively.

Results

No difference was found in the percentages of T lymphocyte subsets between the two groups (p > 0.05). Serum IL-10 levels were similar (p > 0.05), whereas nasal IL-10 was lower in AR subjects compared to control group (2.22 ± 0.91 and 3.12 ± 1.45 pg/ml, respectively) (p < 0.05). Mean serum and nasal IL-17 were higher in AR (107.7 ± 79.61 and 527.36 ± 738.7 pg/ml) than the control group (76.29 ± 28.94 and 328.9 ± 430.8 pg/ml) (p < 0.05 and p > 0.05). There were no significant differences in serum and nasal neopterin levels (p > 0.05).

Conclusions

Although there were no differences in the distribution of lymphocyte subsets between the AR and control groups, the finding of higher levels of serum and nasal IL-17 and lower levels of nasal IL-10 support the cytokine imbalance in the pathogenesis of AR.

Meng Y, Wang C, Zhang L (2019) Recent developments and highlights in allergic rhinitis. Allergy. https://doi.org/10.1111/all.14067 CrossRefPubMedPubMedCentral

Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061CrossRef

Xu G, Mou Z, Jiang H, Cheng L, Shi J, Xu R, Oh Y, Li H (2007) A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis. Laryngoscope 117(5):876–880CrossRef

Palomares O, Martin-Fontecha M, Lauener R, Traidl-Hoffmann C, Cavkaytar O, Akdis M, Akdis CA (2014) Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-beta. Genes Immun 15(8):511–520. https://doi.org/10.1038/gene.2014.45 CrossRefPubMed

Shevach EM (2001) Certified professionals: cD4(+)CD25(+) suppressor T cells. J Exp Med 193(11):F41–F46CrossRef

Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, Lam CW (2001) Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 125(2):177–183CrossRef

Barczyk A, Pierzchala W, Sozanska E (2003) Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med 97(6):726–733CrossRef

Li CW, Lu HG, Chen DH, Lin ZB, Wang DY, Li TY (2014) In vivo and in vitro studies of Th17 response to specific immunotherapy in house dust mite-induced allergic rhinitis patients. PLoS One 9(3):e91950. https://doi.org/10.1371/journal.pone.0091950 CrossRefPubMedPubMedCentral

Tsvetkova-Vicheva VM, Gecheva SP, Komsa-Penkova R, Velkova AS, Lukanov TH (2014) IL-17 producing T cells correlate with polysensitization but not with bronchial hyperresponsiveness in patients with allergic rhinitis. Clin Transl Allergy 4(1):3. https://doi.org/10.1186/2045-7022-4-3 CrossRefPubMedPubMedCentral

10.

Nagalakshmi ML, Murphy E, McClanahan T, de Waal Malefyt R (2004) Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol 4(5):577–592. https://doi.org/10.1016/j.intimp.2004.01.007 CrossRefPubMed

11.

Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K (1998) Role of interleukin 10 in specific immunotherapy. J Clin Invest 102(1):98–106. https://doi.org/10.1172/JCI2250 CrossRefPubMedPubMedCentral

12.

Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H, Kegel C, Disch R, Schmidt-Weber CB, Blaser K, Akdis CA (2004) Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199(11):1567–1575CrossRef

13.

Enk AH, Angeloni VL, Udey MC, Katz SI (1993) Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 151(5):2390–2398PubMed

14.

Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY (1998) IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 160(7):3555–3561PubMed

15.

Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M (2008) In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 205(12):2887–2898. https://doi.org/10.1084/jem.20080193 CrossRefPubMedPubMedCentral

16.

Takanaski S, Nonaka R, Xing Z, O’Byrne P, Dolovich J, Jordana M (1994) Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 180(2):711–715CrossRef

17.

Hussein PY, Zahran F, Ashour Wahba A, Ahmad AS, Ibrahiem MM, Shalaby SM, El Tarhouny SA, El Sherbiny HM, Bakr N (2010) Interleukin 10 receptor alpha subunit (IL-10RA) gene polymorphism and IL-10 serum levels in Egyptian atopic patients. J Investig Allergol Clin Immunol 20(1):20–26PubMed

18.

Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM (1997) Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185(6):1089–1099CrossRef

19.

Hoffmann G, Wirleitner B, Fuchs D (2003) Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 52(8):313–321. https://doi.org/10.1007/s00011-003-1181-9 CrossRef

20.

Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H (1984) Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 160(1):310–316CrossRef

21.

Murr C, Widner B, Wirleitner B, Fuchs D (2002) Neopterin as a marker for immune system activation. Curr Drug Metab 3(2):175–187CrossRef

22.

Baumann R, Rabaszowski M, Stenin I, Tilgner L, Scheckenbach K, Wiltfang J, Schipper J, Chaker A, Wagenmann M (2013) Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge. Am J Rhinol Allergy 27(4):266–272. https://doi.org/10.2500/ajra.2013.27.3913 CrossRefPubMed

23.

Genc S, Eroglu H, Kucuksezer UC, Aktas-Cetin E, Gelincik A, Ustyol-Aycan E, Buyukozturk S, Deniz G (2012) The decreased CD4+CD25+FoxP3+ T cells in nonstimulated allergic rhinitis patients sensitized to house dust mites. J Asthma 49(6):569–574CrossRef

24.

Ünüvar S, Erge D, Kılıçarslan B, Gözükara Bağ HG, Çatal F, Girgin G, Baydar T (2019) Neopterin levels and indoleamine 2,3-dioxygenase activity as biomarkers of immune system activation and childhood allergic diseases. Ann Lab Med. 39(3):284–290CrossRef

25.

Pellerin L, Jenks JA, Begin P, Bacchetta R, Nadeau KC (2014) Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 58(2–3):358–368CrossRef

26.

Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA (2005) Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 81(1):45–52. https://doi.org/10.1002/jnr.20522 CrossRefPubMed

27.

Shi HZ, Li S, Xie ZF, Qin XJ, Qin X, Zhong XN (2004) Regulatory CD4+CD25+ T lymphocytes in peripheral blood from patients with atopic asthma. Clin Immunol 113(2):172–178. https://doi.org/10.1016/j.clim.2004.06.009 CrossRefPubMed

28.

Lee JH, Yu HH, Wang LC, Yang YH, Lin YT, Chiang BL (2007) The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 148(1):53–63. https://doi.org/10.1111/j.1365-2249.2007.03329.x CrossRefPubMedPubMedCentral

29.

Zhang Q, Qian FH, Liu H, Zhou LF, Huang M, Zhang XL, Yin KS (2008) Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid. Chin Med J (Engl) 121(3):205–212CrossRef

30.

Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O’Mahony L, Palomares O, Rhyner C, Ouaked N, Schaffartzik A, Van De Veen W, Zeller S, Zimmermann M, Akdis CA (2011) Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127(3):701–721. https://doi.org/10.1016/j.jaci.2010.11.050 CrossRefPubMed

31.

Stelmaszczyk-Emmel A, Zawadzka-Krajewska A, Szypowska A, Kulus M, Demkow U (2013) Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy. Int Arch Allergy Immunol 162(1):16–24. https://doi.org/10.1159/000350769 CrossRefPubMed

32.

Geraldes L, Morgado J, Almeida A, Todo-Bom A, Santos P, Paiva A, Cheira C, Pais ML (2010) Expression patterns of HLA-DR+ or HLA-DR− on CD4+/CD25++/CD127low regulatory T cells in patients with allergy. J Investig Allergol Clin Immunol 20(3):201–209PubMed

33.

Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, Rudin A (2004) Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 34(9):1364–1372. https://doi.org/10.1111/j.1365-2222.2004.02067.x CrossRefPubMed

34.

Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, Carr VA, Robinson DS (2004) Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363(9409):608–615. https://doi.org/10.1016/S0140-6736(04)15592-X CrossRefPubMed

35.

Bellinghausen I, Klostermann B, Knop J, Saloga J (2003) Human CD4+CD25 +T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 111(4):862–868CrossRef

Title: The role of regulatory T cells in allergic rhinitis and their correlation with IL-10, IL-17 and neopterin levels in serum and nasal lavage fluid
Authors: Kadriye Erkan
Mete K. Bozkurt
Hasibe Artaç
Hülya Özdemir
Ali Ünlü
Emine N. Korucu
Çağdaş Elsürer
Publication date: 01-04-2020
Publisher: Springer Berlin Heidelberg
Keywords: Allergic Rhinitis
Cytokines
Published in: European Archives of Oto-Rhino-Laryngology / Issue 4/2020
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-020-05811-4

ACC 2024 Congress

Springer Medicine

The role of regulatory T cells in allergic rhinitis and their correlation with IL-10, IL-17 and neopterin levels in serum and nasal lavage fluid

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2020

Middle-ear cholesteatoma co-existing with labyrinthine fistula and vestibular schwannoma

Tympanomeatal flap creation in endoscopic stapedotomy: cautery vs. cold instrumentation

Predicting the factors associated with central lymph node metastasis in clinical node-negative (cN0) papillary thyroid microcarcinoma

Dyna-CT of the temporal bone for case-specific three-dimensional rendering of the stapedial muscle for planning of electrically evoked stapedius reflex threshold determination during cochlear implantation directly from the stapedius muscle via a retrofacial approach: a pilot study

Videolaryngoscope-assisted coblation of epiglottic cysts

Redefining adequate margins in oral squamous cell carcinoma: outcomes from close and positive margins